Mandate Vinge has advised Industrifonden and Investinor in connection with a sale of shares in Calliditas

January 10, 2020

Vinge has advised Industrifonden and Investinor in connection with a sale of in total approximately 2,300,000 shares in Calliditas Therapeutics AB (publ) to two investors for a total value of approximately USD 17,000,000.

Calliditas is listed on Nasdaq Stockholm and focuses on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which the company can partially or completely participate in the commercialization efforts.

Vinge’s team consisted of Dain Hård Nevonen, Sofie Bjärtun, Nils Fredrik Dehlin and Hampus Olsson.

Covid-19: Checklist of legal issues for companies

The Covid-19 situation has had a material negative effect on a large number of Swedish businesses and it has also led to considerable fluctuations on the financial markets. We have gathered together a number of questions and answers which we frequently encounter in our practice to help companies navigate the situation.
March 27, 2020

Covid-19 and its impact on international trade

Vinge’s experts within trade and shipping summarise some observations on how Corona as of today impact international trade.
March 27, 2020

Brexit and cross-border telecommunications services

The Transition Period entered into force immediately upon the United Kingdom’s withdrawal from the European Union on 31 January 2020. During this period, EU law will continue to be applicable to and within the UK. What is to follow the Transition Period is uncertain and subject to ongoing negotiations between the EU and the UK. However, it is likely that the regulation of cross-border telecommunications services will be affected. In this context, this note discusses various implications of Brexit.
March 25, 2020